Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

David Suhocki

Physician Assistant, Medical Wolcott, CT Physician Assistant

NPI 1861483414 CMS profile 10529902

464 Wolcott Rd, Wolcott, CT 06716

Open in the dashboard

General payments

$6,226

119 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, David Suhocki of Wolcott, CT is reported in the CMS Open Payments database as having received $6,226 across 119 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 91st percentile of Physician Assistant, Medical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $707 33
2024 General $4,497 25
2023 General $469 26
2022 General $284 20
2021 General $270 15

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • David Suhocki
  • Physician Assistant, Medical median
  • Middle half of Physician Assistant, Medical
  • National median

In program year 2025, general payments to David Suhocki were reported at $707. Among 16,675 Physician Assistant, Medical profiles paid that year, the median was $214 and the middle half received between $62 and $755.

Show as a table
Year David Suhocki Physician Assistant, Medical median Middle half National median
2019 $0 $61 $19–$193 $163
2020 $0 $20 $14–$64 $114
2021 $270 $156 $41–$563 $132
2022 $284 $185 $55–$649 $149
2023 $469 $199 $58–$717 $160
2024 $4,497 $206 $62–$740 $164
2025 $707 $214 $62–$755 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AbbVie, Inc. $5,206 70 payments
  2. Janssen Biotech, Inc. $360 17 payments
  3. Amgen Inc. $213 13 payments
  4. E.R. Squibb & Sons, L.L.C. $146 7 payments
  5. UCB, Inc. $114 3 payments
  6. Lilly USA, LLC $48 2 payments
  7. Galderma Laboratories, L.P. $43 2 payments
  8. Novartis Pharmaceuticals Corporation $40 2 payments
  9. Genzyme Corporation $27 1 payment
  10. Pfizer Inc. $23 1 payment
  11. Other $5 1 payment

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Consulting Fee $4,000 2 payments
  2. Food and Beverage $2,083 115 payments
  3. Education $100 1 payment
  4. Travel and Lodging $44 1 payment
Products named General payments · program years 2021–2025
  1. RINVOQ $4,343 20 payments
  2. SKYRIZI Immunology $792 47 payments
  3. TREMFYA $360 17 payments
  4. Otezla $194 12 payments
  5. SOTYKTU $146 7 payments
  6. Bimzelx $114 3 payments
  7. HUMIRA $63 3 payments
  8. EBGLYSS $48 2 payments
  9. SKYRIZI Immunology $47 2 payments
  10. Enbrel $42 3 payments
  11. Other $116 6 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 23 drugs

Part D claims

1,190

Median for Physician Assistant: 241

Drug cost

$163,129

Median for Physician Assistant: $4,110

Branded share of claims

32%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Dupixent Pen Dupilumab Brand 33 $131,524
Betamethasone Diprop Augmented Betamethasone/Propylene Glyc Brand 199 $7,612
Ivermectin Generic 17 $4,096
Tacrolimus Generic 32 $3,221
Fluorouracil Generic 31 $2,462
Metronidazole Generic 32 $2,330
Ciclopirox Ciclopirox Olamine Brand 101 $1,826
Triamcinolone Acetonide Generic 183 $1,822
Doxycycline Hyclate Generic 104 $1,339
Clobetasol Propionate Generic 37 $924

The 10 drugs with the highest cost, of 23 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 45 billing codes

Paid by Medicare

$87,687

Medicare's payments for the services billed

Medicare patients

497

Average age 76

Services billed

2,120

231 women, 266 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 74%
Arthritis 53%
Ischemic heart disease 28%
Diabetes 24%
Atrial fibrillation 22%
Chronic kidney disease 19%
Cancer 17%
Osteoporosis 15%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 6 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
RINVOQ
  • AbbVie, Inc. $4,114
$4,114 — —
SKYRIZI
  • AbbVie, Inc. $159
$159 — —
SOTYKTU
  • E.R. Squibb & Sons, L.L.C. $60
$60 — —
Otezla
  • Amgen Inc. $54
$54 — —
Bimzelx
  • UCB, Inc. $46
$46 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 6 in the dashboard with a free account

Records

119 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant, Medical in Connecticut

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record